NCT03717181View on ClinicalTrials.gov

Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease

NO_LONGER_AVAILABLEEXPANDED_ACCESS
Timeline

Start Date

Not specified

Conditions
Polycystic Kidney
Interventions
DRUG

Lixivaptan

Daily dose of lixivaptan optimized using a predetermined titration protocol.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors
All Listed Sponsors
lead

Palladio Biosciences

INDUSTRY

NCT03717181 - Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease | Biotech Hunter | Biotech Hunter